本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Theravance Biopharma Inc.

17.03
0.0000
成交量:1.42萬
成交額:24.20萬
市值:8.83億
市盈率:16.30
高:17.04
開:17.04
低:17.03
收:17.03
52周最高:21.03
52周最低:13.08
股本:5,182.83萬
流通股本:2,585.69萬
量比:0.34
換手率:0.05%
股息:- -
股息率:- -
每股收益(TTM):1.05
每股收益(LYR):2.06
淨資產收益率:20.91%
總資產收益率:1.33%
市淨率:3.05
市盈率(LYR):8.27

資料載入中...

2023/06/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/05/18

[修訂]季度報告

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
2023/05/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/05/10

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/05/08

重要事件披露

8-K - Current report
2023/05/03

重要事件披露

8-K - Current report
2023/04/17

重要事件披露

8-K - Current report
2023/04/14

關聯方擬減持公告

144 - Report of proposed sale of securities
2023/04/12

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2023/04/11

重要事件披露

8-K - Current report
2023/03/13

重要事件披露

8-K - Current report
2023/03/01

重要事件披露

8-K/A [Amend] - Current report
2023/03/01

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/02/28

重要事件披露

8-K - Current report
2023/02/27

重要事件披露

8-K - Current report
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/13

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/09

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals